ANI Pharmaceuticals (ANIP) PT Lifted to $79 at Guggenheim

February 19, 2015 12:52 PM

Guggenheim analyst Louise Chen reiterated a Buy rating and boosted her price target on ANI Pharmaceuticals (NASDAQ: ANIP) to $79.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found